Skip to content

Member

Adam JARUBAS

EPP · Poland

Group
EPP PPE
Country
Poland
Roll-call participation
74.3 %ⓘ of 5 928 roll calls in office · chamber median 90.2 % · whole term, roll calls
With majority line
90.1 %ⓘ of 4 404 votes where the group had a line · EPP median 93.6 %
More facts (5)
National party
PSL Polskie Stronnictwo Ludowe
In office
Since 16 Jul 2024
Against clear line
306 of 4 222 votesⓘ
Committees
ENVI (substitute), ITRE, SANT (chair)
Member id
197517
More

Record

The member’s figures against the median of their group and of the chamber. Each vote counts the member in the group they belonged to that day.

Roll-call participation ⓘ

74.3 %

4 404 of 5 928 roll calls while in office

EPP median: 89.9 % (−15.6 pts)

Chamber median: 90.2 %

With majority line ⓘ

90.1 %

3 966 of 4 404 votes where their group had a line

EPP median: 93.6 % (−3.6 pts)

Against clear line ⓘ

7.2 %

306 of 4 222 votes where their group had a clear line

213 opposite (for ↔ against), 93 abstained against the line

Abstention ⓘ

4.3 %

191 of 4 404 votes cast

Participation 74.3 % — EPP median 89.9 %, 196 members.ⓘ
Data as a table
Participation among the 196 members of the EPP with enough votes.
FigureParticipation
Adam JARUBAS74.3 %
EPP median89.9 %
Lowest in the group17.0 %
Highest in the group99.6 %
Members196
With majority line 90.1 % — EPP median 93.6 %, 196 members.ⓘ
Data as a table
With majority line among the 196 members of the EPP with enough votes.
FigureWith majority line
Adam JARUBAS90.1 %
EPP median93.6 %
Lowest in the group70.2 %
Highest in the group99.5 %
Members196
  • Whole term, 5 928 roll-call votes. The dots are the other members of EPP; no ranks.
  • “No vote recorded” is not the same as absent: leave, illness and chairing the sitting look the same.
  • A group’s line is inferred from its members’ votes — Parliament publishes no whip.

Votes, 620

Export

Every final roll-call vote of the term with the member’s position, newest first.

Result: for–against–abstained. Majority line: how most of the member’s group voted that day (“Tie” when no position won). ≠ group marks a vote otherwise than a clear line (at least two thirds, with at least 10 members voting) of their group.
DateDecisionResultPositionMajority line
23 Oct 2024Guidelines for the employment policies of the Member States Passed 444 for, 179 against, 20 abstainedPosition: For Majority line: For
23 Oct 2024General budget of the European Union for the financial year 2025 – all sections Resolution rejected 233 for, 360 against, 59 abstainedPosition: For Majority line: For
22 Oct 2024Establishing the Ukraine Loan Cooperation Mechanism and providing exceptional macro-financial assistance to Ukraine Passed 518 for, 56 against, 61 abstainedPosition: For Majority line: For
22 Oct 2024Draft amending budget No 2/2024: entering the surplus of the financial year 2023 Passed 531 for, 91 against, 35 abstainedPosition: For Majority line: For
22 Oct 2024Draft amending budget No 4/2024: update of revenue (own resources) and adjustments to some decentralised agencies Passed 522 for, 115 against, 25 abstainedPosition: For Majority line: For
22 Oct 2024Mobilisation of the European Globalisation Adjustment Fund: application EGF/2024/001 BE/Match-Smatch Passed 601 for, 47 against, 17 abstainedPosition: For Majority line: For
22 Oct 20242022 discharge: EU general budget – European Council and Council Passed 431 for, 131 against, 83 abstainedPosition: For Majority line: For
10 Oct 2024The cases of unjustly imprisoned Uyghurs in China, notably Ilham Tohti and Gulshan Abbas Adopted 540 for, 23 against, 47 abstainedPosition: For Majority line: For
9 Oct 2024Strengthening Moldova’s resilience against Russian interference ahead of the upcoming presidential elections and a constitutional referendum on EU integration Adopted 508 for, 53 against, 104 abstainedPosition: For Majority line: For
9 Oct 2024The democratic backsliding and threats to political pluralism in Georgia Adopted 495 for, 73 against, 86 abstainedPosition: For Majority line: For
8 Oct 2024Mobilisation of the European Union Solidarity Fund: assistance to Italy, Slovenia, Austria, Greece and France further to natural disasters that occurred in 2023 Passed 632 for, 7 against, 3 abstainedPosition: No vote recorded Majority line: For
19 Sept 2024EU/USA Agreement on the launch of Galileo satellites from U.S. Territory Consent given 582 for, 16 against, 17 abstainedPosition: No vote recorded Majority line: For
19 Sept 2024The deteriorating situation of women in Afghanistan due to the recent adoption of the law on the ‘Promotion of Virtue and Prevention of Vice’ Adopted 565 for, 8 against, 43 abstainedPosition: No vote recorded Majority line: For
19 Sept 2024The severe situation of political prisoners in Belarus Adopted 549 for, 21 against, 37 abstainedPosition: No vote recorded Majority line: For
19 Sept 2024The case of José Daniel Ferrier García in Cuba Adopted 380 for, 182 against, 51 abstainedPosition: No vote recorded Majority line: For
19 Sept 2024Continued financial and military support to Ukraine by EU Member States Adopted 425 for, 131 against, 63 abstainedPosition: No vote recorded Majority line: For
19 Sept 2024Situation in Venezuela Adopted 309 for, 201 against, 12 abstainedPosition: No vote recorded Majority line: For
18 Sept 2024Maximum residue levels for carbendazim and thiophanate-methyl Objection passed 516 for, 129 against, 27 abstainedPosition: No vote recorded Majority line: Against
18 Sept 2024Maximum residue levels for cyproconazole Objection passed 522 for, 127 against, 28 abstainedPosition: No vote recorded Majority line: Against
17 Jul 2024The need for the EU's continuous support for Ukraine Adopted 495 for, 137 against, 47 abstainedPosition: For Majority line: For

Roll-call participation

One cell per sitting while in office, shaded by the share of that day’s roll calls the member voted in. The official attendance register is kept separately by Parliament.

No vote recorded on 31 of 107 sittings with roll calls.

"No vote recorded" is not the same as absent: leave, illness and chairing the sitting look the same.

Data as a table
Roll calls held at each sitting while in office and how many of them the member voted in.
SittingRoll callsVoted in
17 Jul 20242322
18 Jul 202411
16 Sept 202420
18 Sept 202420
19 Sept 2024920
7 Oct 202420
8 Oct 202410
9 Oct 20241818
10 Oct 202444
21 Oct 202422
22 Oct 20241010
23 Oct 2024129128
24 Oct 20241313
13 Nov 202422
14 Nov 20243636
25 Nov 202420
26 Nov 2024180
27 Nov 20241111
28 Nov 2024570
17 Dec 20241312
18 Dec 20243333
19 Dec 2024450
20 Jan 202520
21 Jan 202511
22 Jan 202522
23 Jan 2025450
10 Feb 202510
11 Feb 20253232
12 Feb 20251010
13 Feb 2025300
10 Mar 202522
11 Mar 202598
12 Mar 2025228226
13 Mar 20252424
31 Mar 202533
1 Apr 20253534
2 Apr 2025251249
3 Apr 20256261
5 May 202555
6 May 20251010
7 May 2025220219
8 May 2025103102
21 May 202522
22 May 20255352
16 Jun 202520
17 Jun 20254141
18 Jun 20259190
19 Jun 2025870
7 Jul 202511
8 Jul 20255555
9 Jul 2025134131
10 Jul 20253636
8 Sept 202511
9 Sept 2025101100
10 Sept 20253433
11 Sept 20256969
6 Oct 202522
7 Oct 202555
8 Oct 20255552
9 Oct 20256565
20 Oct 202530
21 Oct 20251313
22 Oct 2025186185
23 Oct 2025550
13 Nov 2025267261
24 Nov 202530
25 Nov 2025750
26 Nov 20251000
27 Nov 20251250
15 Dec 202544
16 Dec 20256666
17 Dec 20254323
18 Dec 20254242
20 Jan 20266767
21 Jan 2026112108
22 Jan 20265857
9 Feb 202622
10 Feb 20263837
11 Feb 20261313
12 Feb 2026141139
24 Feb 20264342
9 Mar 202610
10 Mar 20261970
11 Mar 2026600
12 Mar 2026340
25 Mar 202630
26 Mar 20266969
27 Apr 202620
28 Apr 20262250
29 Apr 2026296293
30 Apr 20266867
18 May 202640
19 May 202633
20 May 20269696
21 May 2026980
15 Jun 202622
16 Jun 20264040
17 Jun 2026127126
18 Jun 20267777
6 Jul 202622
7 Jul 20267272
8 Jul 2026144141
9 Jul 2026670
14 Sept 202611
15 Sept 2026155142
16 Sept 20268077
17 Sept 2026124122

Voting neighbours

Members who voted the same way most often in the roll calls they both took part in, within and outside the member’s group (group at the date of each vote), over all roll calls of the term.

At least 200 shared roll calls over at least six months in office together. Within = both sat in the same group on the date of the vote; a member who changed group can appear on both lists. Baseline = the median agreement of all pairs of members of the groups the two sat in on the date of each shared vote (within: the group they shared; outside: the two groups), weighted by the votes they shared in each combination.

Within EPP

Agreement: roll calls where both cast the same position, of the roll calls both voted in while in the same group (“shared”); a count below 50 shared. Baseline: the median agreement of every pair of members of that group.
SelectMemberGroupCountryAgreementBaseline
Krzysztof HETMAN EPPPoland96 % of 4 016 shared89 %
Jacek PROTAS EPPPoland95 % of 4 257 shared89 %
Marta WCISŁO EPPPoland95 % of 4 353 shared89 %
Bogdan Andrzej ZDROJEWSKI EPPPoland95 % of 4 363 shared89 %
Andrzej BUŁA EPPPoland95 % of 4 003 shared89 %
Kamila GASIUK-PIHOWICZ EPPPoland94 % of 4 317 shared89 %
Dariusz JOŃSKI EPPPoland94 % of 4 334 shared89 %
Bartosz ARŁUKOWICZ EPPPoland94 % of 4 178 shared89 %
Andrzej HALICKI EPPPoland94 % of 4 105 shared89 %
Bartłomiej SIENKIEWICZ EPPPoland94 % of 4 317 shared89 %

Show all 10 neighbours

Outside the group

Agreement: roll calls where both cast the same position, of the roll calls both voted in while in different groups (“shared”); a count below 50 shared. Baseline: the median agreement of every pair of members of the groups the two sat in on those votes (groups at the date, weighted by the votes shared in each combination).
SelectMemberGroupCountryAgreementBaseline
Eugen TOMAC RenewRomania81 % of 3 166 shared82 %
Katri KULMUNI RenewFinland81 % of 3 539 shared82 %
Urmas PAET RenewEstonia81 % of 3 836 shared82 %
Dan BARNA RenewRomania80 % of 3 840 shared82 %
Hilde VAUTMANS RenewBelgium80 % of 4 231 shared82 %
Marie-Pierre VEDRENNE Former memberRenewFrance80 % of 1 976 shared82 %
Bart GROOTHUIS RenewNetherlands79 % of 3 307 shared82 %
Jeannette BALJEU RenewNetherlands79 % of 3 942 shared82 %
Ivars IJABS RenewLatvia79 % of 3 424 shared82 %
Benoit CASSART RenewBelgium79 % of 4 014 shared82 %

Show all 10 neighbours

Work

Seats in committees, delegations and intergroups, and the dossiers the member leads, shadows or negotiates.

Seats

Body: the committee, delegation or intergroup, with its kind. Role: the member’s role in it. From, To: the dates of the seat (“now” while it lasts).
BodyRoleFromTo
Committee on the Environment, Climate and Food SafetyENVI CommitteeSubstitute20 Jan 2025now
Committee on Industry, Research and EnergyITRE CommitteeMember19 Jul 2024now
Committee on Public HealthSANT CommitteeChair29 Jan 2025now
Delegation for relations with the People's Republic of ChinaD-CN DelegationMember19 Sept 2024now
Delegation for relations with the Korean PeninsulaDKOR DelegationSubstitute19 Sept 2024now
Intergroup on Anti-CorruptionIG10-01 Intergroup / working groupMember16 Jan 2025now
Committee on the Environment, Public Health and Food SafetyENVI CommitteeSubstitute19 Jul 202419 Jan 2025
Committee on Public HealthSANT CommitteeMember23 Jan 202528 Jan 2025
Subcommittee on Public HealthSANT SubcommitteeChair23 Jul 202419 Jan 2025
Subcommittee on Public HealthSANT SubcommitteeMember19 Jul 202422 Jul 2024

Show all 10 seats

Dossiers

Dossier: the procedure the declaration names (“No dossier named” for a delegation without one). Role: rapporteur, shadow rapporteur, negotiator or delegation. Committee: the committee that appointed them. Date: of the declaration.
DossierRoleCommitteeDate
EU Emissions Trading System: heat and fuel benchmark values for 2026–2030RapporteurENVI2 Sept 2026
Amending Directives 2001/18/EC and 2010/53/EU as regards the placing on the market of genetically modified micro-organisms and the processing of organsRapporteurSANT16 Apr 2026
24th EU-Republic of South Korea Interparliamentary Meeting\nSeoul 27-29 May 2026Official delegationDKOR16 Apr 2026
Amending Regulation (EU) 2023/956 as regards the extension of its scope to downstream goods and anti-circumvention measuresShadow rapporteurENVI16 Apr 2026
No dossier namedOfficial delegationSANT24 Mar 2026
Amending Regulation (EU) 2023/956 as regards the extension of its scope to downstream goods and anti-circumvention measuresShadow rapporteurENVI24 Mar 2026
Laying down the multiannual financial framework for the years 2028 to 2034Opinion rapporteurSANT11 Feb 2026
Guidelines for the 2027 Budget - Section IIIOpinion rapporteurSANT11 Feb 2026
No dossier namedOfficial delegationSANT28 Jan 2026
No dossier namedOfficial delegationSANT9 Oct 2025

Show all 14 dossier roles

Topics they work on (model-assigned)

Counts: dossiers they spoke on, led or amended, and their questions and motions.

In the chamber

Speeches and statements in plenary debates, newest first; the verbatim report is on Parliament’s site.

14 contributions recorded; 2 on behalf of their group; 23 minutes of speaking time.

Show all 14 recent contributions

Questions and motions, 29

Parliamentary questions and motions for resolutions the member authored or co-signed, newest first.

Date: tabled. Title: the question or motion, with its id. Kind: written question or motion for a resolution, with the number of co-authors. Answer: the date of the answer to a question.
DateTitleKindAnswer
22 Jun 2026SCoPAFF’s reclassification of plant protection products E-10-2026-002564Written questionwith 1 co-authorNot yet answered
17 Jun 2026Recognition of obesity as a chronic disease under EU public health policy E-10-2026-002516Written questionwith 17 co-authors24 Aug 2026
25 Mar 2026Ensuring competition and strategic autonomy in the AI gigafactory supply chain E-10-2026-001255Written questionwith 17 co-authors19 Jun 2026
24 Feb 2026Ensuring risk assessment as the basis for proportionate regulation of cosmetic products E-10-2026-000762Written questionwith 20 co-authors16 Apr 2026
18 Feb 2026Inspections to ensure regulatory conformity of cosmetic products in the single market with the Cosmetic Products Regulation E-10-2026-000687Written questionwith 22 co-authorsNot yet answered
18 Feb 2026Checks on the presence of prohibited substances and trace impurities in non-EU cosmetic products entering the single market E-10-2026-000688Written questionwith 21 co-authors21 May 2026
13 Feb 2026Commission proceedings concerning complaint CPLT(2023)02625 on Poland’s restrictions on pharmacy ownership E-10-2026-000645Written questionwith 2 co-authors26 Mar 2026
11 Feb 2026Protecting allergic consumers by harmonising EU ingredient labelling E-10-2026-000591Written questionwith 5 co-authors17 Apr 2026
9 Feb 2026MOTION FOR A RESOLUTION on World Cancer Day B-10-2026-0141Motion for a resolutionwith 18 co-authors—
3 Feb 2026Ensuring patient safety for all Europeans: the need to establish a warning system for disqualified medical professionals E-10-2026-000428Written questionwith 24 co-authors27 Mar 2026
14 Jan 2026MOTION FOR A RESOLUTION seeking an opinion from the Court of Justice on the compatibility with the Treaties of the proposed Partnership Agreement between the European Union and its Member States, of the one part, and the Common Market of the South, the Argentine Republic, the Federative Republic of Brazil, the Republic of Paraguay and the Oriental Republic of Uruguay, of the other part, and the proposed Interim Agreement on Trade between the European Union, of the one part, and the Common Market of the South, the Argentine Republic, the Federative Republic of Brazil, the Republic of Paraguay and the Oriental Republic of Uruguay, of the other part B-10-2026-0060Motion for a resolutionwith 143 co-authors—
18 Dec 2025Exemptions for the life-science value chain in upcoming EU US trade measures E-10-2025-005018Written question12 Feb 2026
8 Dec 2025Ban on the sale of nitrous oxide to the general public O-10-2025-000046Oral questionwith 42 co-authorsNot yet answered
29 Oct 2025Safeguarding the European ferroalloy sector E-10-2025-004242Written questionwith 14 co-authors19 Dec 2025
29 Sept 2025Russian drones violating Poland’s airspace P-10-2025-003780Priority written questionwith 30 co-authors4 Nov 2025
18 Aug 2025Timeline and scope of upcoming rules on bioLNG liquefaction by equivalence E-10-2025-003253Written questionwith 7 co-authors20 Oct 2025
22 Jul 2025Reassessing the timetable and safeguards for ETS2: preventing price shocks and ensuring social readiness E-10-2025-003032Written questionwith 48 co-authors12 Nov 2025
17 Jul 2025Study on the potential costs and impact of the Urban Wastewater Treatment Directive (UWWTD) on the pharmaceutical and cosmetic sectors. E-10-2025-002988Written questionwith 24 co-authors26 Sept 2025
20 Jun 2025Allowing midwives to obtain nursing qualifications in the same way that Directive 2005/36/EC allows nurses to retrain as midwives P-10-2025-002491Priority written question1 Aug 2025
16 Apr 2025Translation of European respiratory infections forecasting into socially available tools E-10-2025-001556Written question18 Jul 2025
17 Mar 2025Addressing resource shuffling and ensuring the CBAM’s (Carbon Border Adjustment Mechanism) effectiveness in the European steel industry E-10-2025-001119Written questionwith 5 co-authors10 Jun 2025
26 Feb 2025Rare diseases P-10-2025-000845Priority written questionwith 7 co-authors2 May 2025
21 Feb 2025Commission’s response to the incomplete implementation of the UN Convention on the Rights of Persons with Disabilities in Member States E-10-2025-000810Written questionwith 50 co-authors27 May 2025
17 Feb 2025EU-Mercosur trade agreement E-10-2025-000716Written questionwith 25 co-authors24 Apr 2025
4 Feb 2025US AI chip export restrictions: a challenge to EU unity and technological sovereignty E-10-2025-000483Written questionwith 17 co-authors8 Apr 2025
9 Dec 2024EU-Mercosur agreement E-10-2024-002829Written questionwith 18 co-authors3 Mar 2025
16 Oct 2024Fund for the protection and development of the frontier regions of countries bordering Ukraine, Belarus and Russia E-10-2024-002090Written questionwith 36 co-authors10 Jan 2025
7 Oct 2024Increase in the Modernisation Fund by 0.5 % of the total quantity of allowances in accordance with Article 10a(5b) of Directive (EU) 2003/87/EC P-10-2024-001971Priority written question31 Oct 2024
17 Jul 2024MOTION FOR A RESOLUTION on the need for the EU’s continuous support for Ukraine B-10-2024-0007Motion for a resolutionwith 50 co-authors—

Amendments tabled in committee, 114

Committee amendment documents that carry amendments by the member, with how many are theirs.

Date: of the amendment document. Text amended: the dossier and the document’s id. Committee: where the amendments were tabled. Amendments: how many in the document are the member’s.
DateText amendedCommitteeAmendments
11 Sept 2026Modernised rules for patients’ rights in cross-border healthcare SANT-AM-792154 SANT21
11 Sept 2026Modernised rules for patients’ rights in cross-border healthcare SANT-AM-792014 SANT35
28 Jul 2026Amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and amending Regulation (EU) 2022/123 as regards the support of the European Medicines Agency for the expert panels on medical devices and Regulation (EU) 2024/1689 as regards the list of Union harmonisation legislation referred to in its Annex I SANT-AM-791890 SANT3
28 Jul 2026Amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and amending Regulation (EU) 2022/123 as regards the support of the European Medicines Agency for the expert panels on medical devices and Regulation (EU) 2024/1689 as regards the list of Union harmonisation legislation referred to in its Annex I SANT-AM-791887 SANT5
28 Jul 2026Amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and amending Regulation (EU) 2022/123 as regards the support of the European Medicines Agency for the expert panels on medical devices and Regulation (EU) 2024/1689 as regards the list of Union harmonisation legislation referred to in its Annex I SANT-AM-791891 SANT8
27 Jul 2026Amending Regulations (EU) 2016/679, (EU) 2018/1724, (EU) 2018/1725, (EU) 2023/2854 and Directives 2002/58/EC, (EU) 2022/2555 and (EU) 2022/2557 as regards the simplification of the digital legislative framework, and repealing Regulations (EU) 2018/1807, (EU) 2019/1150, (EU) 2022/868, and Directive (EU) 2019/1024 (Digital Omnibus) CJ72-AM-791073 CJ722
27 Jul 2026Amending Regulations (EU) 2016/679, (EU) 2018/1724, (EU) 2018/1725, (EU) 2023/2854 and Directives 2002/58/EC, (EU) 2022/2555 and (EU) 2022/2557 as regards the simplification of the digital legislative framework, and repealing Regulations (EU) 2018/1807, (EU) 2019/1150, (EU) 2022/868, and Directive (EU) 2019/1024 (Digital Omnibus) CJ72-AM-791874 CJ722
27 Jul 2026Amending Regulations (EU) 2016/679, (EU) 2018/1724, (EU) 2018/1725, (EU) 2023/2854 and Directives 2002/58/EC, (EU) 2022/2555 and (EU) 2022/2557 as regards the simplification of the digital legislative framework, and repealing Regulations (EU) 2018/1807, (EU) 2019/1150, (EU) 2022/868, and Directive (EU) 2019/1024 (Digital Omnibus) CJ72-AM-791873 CJ7219
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790932 CJ537
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790938 CJ538

Show all 114 amendment documents

Connections

Dossiers they lead or shadow, committees, party, delegation and other related pages.

Political group

National delegation

  • Delegation Poland National delegation

Sources & citation

Where the facts on this page come from, and how to cite it.

Data source
Licensed CC BY 4.0.
Data version
data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1 · methods
Retrieved
25 September 2026

Cite as

EU Parl Watch Research (2026). “Adam JARUBAS”. Member record. memberId 197517. EU Parl Watch Research. https://news.eu-parl.st-solutions.dev/members/197517?docs=all&page=13&rows=all (retrieved 25 September 2026). Official source: Member’s profile, European Parliament, https://www.europarl.europa.eu/meps/en/197517. Data: EP Open Data: member record, https://data.europarl.europa.eu/api/v2/meps/197517?format=application%2Fld%2Bjson (CC BY 4.0); data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1.
BibTeX
@misc{epw-member-197517,
  author = {{EU Parl Watch Research}},
  title = {{Adam JARUBAS}},
  year = {2026},
  howpublished = {\url{https://news.eu-parl.st-solutions.dev/members/197517?docs=all&page=13&rows=all}},
  url = {https://news.eu-parl.st-solutions.dev/members/197517?docs=all&page=13&rows=all},
  urldate = {2026-09-25},
  publisher = {EU Parl Watch Research},
  note = {Member record. memberId 197517. Official source: https://www.europarl.europa.eu/meps/en/197517. Data: EP Open Data: member record (CC BY 4.0); data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1}
}